223 related articles for article (PubMed ID: 18072624)
21. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
[TBL] [Abstract][Full Text] [Related]
22. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
[TBL] [Abstract][Full Text] [Related]
23. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
Chan JY; Siu KP; Fung KP
Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
[TBL] [Abstract][Full Text] [Related]
24. [Orphanin FQ combined with adriamycin reverses multi-drug resistance of K562/ADM and its molecular mechanism].
Wang XX; Liu XQ; Zhang W; Chen X; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):574-8. PubMed ID: 22739158
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
26. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
Shen Y; Chen G; Cai X
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809
[TBL] [Abstract][Full Text] [Related]
27. MDR reversal activity of bromotetrandrine in vitro and in vivo.
Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
[TBL] [Abstract][Full Text] [Related]
28. [Effect of phenylhexyl isothiocyanate on adriamycin resistance of K562/A02 cell line].
Yuang P; Chen BA; Cheng J; Ma XD; Liu DL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):352-7. PubMed ID: 19379565
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines.
Zhao YY; Yu L; Liu BL; He XJ; Zhang BY
Mol Med Rep; 2015 Nov; 12(5):7335-43. PubMed ID: 26459009
[TBL] [Abstract][Full Text] [Related]
30. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
Chen D; Chan R; Waxman S; Jing Y
Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
Wang X; Kong L; Zhao J; Yang P
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
[TBL] [Abstract][Full Text] [Related]
33. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
Ong PS; Chan SY; Ho PC
Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
[TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012
[TBL] [Abstract][Full Text] [Related]
35. [Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin].
Liu H; Fu RY; Liao QK; Li FY; Zhu YP; Gao J; Mao YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):133-7. PubMed ID: 19292063
[TBL] [Abstract][Full Text] [Related]
36. [Effects of As2O3 in combination with TPA on K562 cells].
Yuan FF; Zhang XH; Mi RH; Fan RH; Yin QS; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):943-9. PubMed ID: 25130808
[TBL] [Abstract][Full Text] [Related]
37. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
[TBL] [Abstract][Full Text] [Related]
38. [Reversal of multidrug resistance by lomerizine in K562/ADM cells].
Zhu HJ; Wu YL; Liu GQ
Yao Xue Xue Bao; 2004 May; 39(5):333-7. PubMed ID: 15338873
[TBL] [Abstract][Full Text] [Related]
39. Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug-sensitive and -resistant leukemia cells.
Chen J; Wei H; Xie B; Wang B; Cheng J; Cheng J
Leuk Res; 2012 Dec; 36(12):1526-35. PubMed ID: 22959511
[TBL] [Abstract][Full Text] [Related]
40. [Reversal effect of sodium selenite on multidrug resistance in K562/ADR cell line and its mechanisms].
Cui J; Ding J; Wu YP; Liu FQ; Liu XC; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):756-61. PubMed ID: 17708798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
